טוען...

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study

Lenalidomide is an immunomodulating derivative of thalidomide, which shows anti-tumor activity against myeloma cells with immunomodulation including augmentation of T-cell and natural killer cell function. Continuous treatment with this agent shows better survival benefit in patients with multiple m...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Front Nutr
Main Authors: Ito, Tomoki, Konishi, Akiko, Tsubokura, Yukie, Azuma, Yoshiko, Hotta, Masaaki, Yoshimura, Hideaki, Nakanishi, Takahisa, Fujita, Shinya, Nakaya, Aya, Satake, Atsushi, Ishii, Kazuyoshi, Nomura, Shosaku
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6110850/
https://ncbi.nlm.nih.gov/pubmed/30186837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnut.2018.00072
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!